Alternative agents in refractory chronic urticaria: evidence and considerations on their selection and use.

@article{Khan2013AlternativeAI,
  title={Alternative agents in refractory chronic urticaria: evidence and considerations on their selection and use.},
  author={David Khan},
  journal={The journal of allergy and clinical immunology. In practice},
  year={2013},
  volume={1 5},
  pages={
          433-440.e1
        }
}
Patients with chronic urticaria (CU) who are refractory to antihistamines are frequently encountered by allergy specialists. Several alternative agents have been used to treat these patients; however, the evidence to support these agents is generally limited. This review focuses on some of the more commonly used alternative agents in refractory CU, including anti-inflammatory agents (montelukast, hydroxychloroquine, dapsone, sulfasalazine, methotrexate, colchicine), immunosuppressants… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 21 CITATIONS

Treatment of chronic urticaria in children with antihistamines and cyclosporine.

  • The journal of allergy and clinical immunology. In practice
  • 2014
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Evaluating and managing chronic idiopathic urticaria in adults.

  • JAAPA : official journal of the American Academy of Physician Assistants
  • 2018

Guideline of Chronic Urticaria Beyond

  • Allergy, asthma & immunology research
  • 2016
VIEW 3 EXCERPTS
CITES BACKGROUND